Diagnostic Value of TROP-2 and CK19 Expression in Papillary Thyroid Carcinoma in Both Surgical and Cytological Specimens

被引:13
|
作者
Abdou, Asmaa Gaber [1 ]
Shabaan, Mohammed [1 ]
Abdallha, Rania [1 ]
Nabil, Nehal [1 ]
机构
[1] Menoufia Univ, Fac Med, Dept Pathol, Gamal Abd Etnaser St 32511, Shebein Elkom, Egypt
来源
CLINICAL PATHOLOGY | 2019年 / 12卷
关键词
PTC; diagnosis; CK19; TROP-2; cytology; immunohistochemistry; CYTOKERATIN; 19; DIFFERENTIAL-DIAGNOSIS; FOLLICULAR VARIANT; GALECTIN-3; HBME-1; UTILITY; IMMUNOHISTOCHEMISTRY; LESIONS; BENIGN; MARKER;
D O I
10.1177/2632010X19863047
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Papillary thyroid carcinoma (PTC) represents the most common primary malignant thyroid tumor and its diagnosis is dependent on the presence of classic nuclear features that are sometimes seen in some non-neoplastic and benign lesions. Several immunohistochemical markers are used individually or in combination to help in differentiation of PTC from mimickers. The aim of the current study was to assess the diagnostic value of TROP-2 and cytokeratin 19 (CK19) expression in differentiating PTC from other mimickers both singly and in combination. The current study was carried out on 77 surgical specimens (56 PTC and 21 non-neoplastic cases) and 12 cytological specimens (4 THY2, 6 THY4, and 2 THY5). TROP-2 was negative in 81% of non-neoplastic surgical specimens and in 100% of THY2 cytological specimens while it was positive in 71.4% of PTC surgical specimens and 100% of THY4/THY5 cytological specimens. Sensitivity and specificity of TROP-2 positive expression for diagnosis of PTC in surgical specimens reached 71% and 81%. respectively, while it reached 100% for both in cytological specimens. Cytokeratin 19 showed positive expression in 85.7% of non-neoplastic surgical specimens and in 92.9% of PTC surgical specimens. Cytokeratin 19 showed negative expression in 75% of Thy2 cases while it was positive in all studied Thy4 and Thy5 cases. Sensitivity and specificity of CK19 total estimated score for diagnosis of PTC in surgical specimens were 78.6% and 66.7%. respectively, while it reached 100% and 75% in cytological specimens. Positive TROP-2 and CK19 expression in PTC were associated with lymph node metastasis. TROP-2 is a specific rather than sensitive marker while CK19 is a sensitive rather than specific marker in differentiating PTC from other mimickers in surgical specimens. The diagnostic validity of both markers was superior in diagnosis of classic PTC compared with follicular variant PTC. TROP-2 is superior to CK19 in diagnosis of PTC in cytological specimens. Both TROP-2 and CK19 could be used preoperatively in adjunct to hematoxylin and eosin for more confident diagnosis of thyroid cytology and along with radiology as predictors of lymph node metastasis.
引用
收藏
页数:16
相关论文
共 46 条
  • [31] Clinical significance of HBME-1,Galectin-3,and CK19 expression and the status of BRAF mutation in papillary thyroid carcinoma
    Li Zheng
    Min Zhao
    Xiangyang Hu
    Jin Huang
    Ling Ang
    Hongguang Hu
    Qiang Zou
    Jin Wang
    Mingqiang Liu
    Yang Zhao
    OncologyandTranslationalMedicine, 2016, 2 (04) : 174 - 178
  • [32] Clinicopathological characterization and prognostic implication of FOXP3 and CK19 expression in papillary thyroid carcinoma and concomitant Hashimoto's thyroiditis
    Mohamed, Salem Youssef
    Ibrahim, Taiseer R.
    Elbasateeny, Samah S.
    Abdelaziz, Lobna A.
    Farouk, Shaimaa
    Yassin, Mahmoud Abdou
    Embaby, Ahmed
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [33] Application of CD56, P63 and CK19 immunohistochemistry in the diagnosis of papillary carcinoma of the thyroid
    Dina El Demellawy
    Ahmed Nasr
    Salem Alowami
    Diagnostic Pathology, 3
  • [34] Immunohistochemical markers in diagnosis of papillary thyroid carcinoma: utility of HBME1 combined with CK19 immunostaining
    Nasr, Michel R.
    Mukhopadhyay, Sanjay
    Zhang, Shengle
    Katzenstein, Anna-Luise A.
    MODERN PATHOLOGY, 2006, 19 (12) : 1631 - 1637
  • [35] The Significance of TROP2 Expression in Predicting BRAF Mutations in Papillary Thyroid Carcinoma
    Kong, Joon Seog
    Kim, Hyeon Jin
    Kim, Min-Jung
    Kim, Areumnuri
    Lee, Dalnim
    Han, Kanghee
    Park, Sunhoo
    Koh, Jae Soo
    Myung, Jae Kyung
    JOURNAL OF PATHOLOGY AND TRANSLATIONAL MEDICINE, 2018, 52 (01) : 14 - 20
  • [36] NUCLEAR CK19-IMMUNOPOSITIVE PSEUDOINCLUSIONS AS A NEW ADDITIONAL OBJECTIVE DIAGNOSTIC FEATURE OF PAPILLARY THYROID CARCINOMA
    Domagala, Pawel
    Domagala, Wenancjusz
    POLISH JOURNAL OF PATHOLOGY, 2020, 71 (01) : 1 - 6
  • [37] Diagnostic utility of cytokeratin 19 expression in multinodular goiter with papillary areas and papillary carcinoma of thyroid
    Erkilic, S
    Aydin, A
    Koçer, NE
    ENDOCRINE PATHOLOGY, 2002, 13 (03) : 207 - 211
  • [38] Diagnostic value of differential expression of CK19, galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: an immunohistochemical tissue microarray analysis
    Barroeta, J. E.
    Baloch, Z. W.
    Lal, P.
    Pasha, T. L.
    Zhang, P. J.
    LiVolsi, V. A.
    ENDOCRINE PATHOLOGY, 2006, 17 (03) : 225 - 234
  • [39] Diagnostic value of differential expression of CK19, galectin-3, HBME-1, ERK, RET, and p16 in benign and malignant follicular-derived lesions of the thyroid: An immunohistochemical tissue microarray analysis
    J. E. Barroeta
    Z. W. Baloch
    P. Lal
    T. L. Pasha
    P. J. Zhang
    V. A. LiVolsi
    Endocrine Pathology, 2006, 17 : 225 - 234
  • [40] Expression of CK-19, cErbB2, galectin-3, and p53 in papillary thyroid carcinomas
    Seckin, Selda
    Karagece, Uelker
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2010, 40 (02) : 207 - 212